No association between electrodermal hyporesponsivity and enlarged cavum septi pellucidi in schizophrenia [Editorial] (2007)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- Assunto: ESQUIZOFRENIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Schizophrenia research
- ISSN: 0920-9964
- Volume/Número/Paginação/Ano: v. 95, p. 256-258, 2007
-
ABNT
CRIPPA, José Alexandre de Souza et al. No association between electrodermal hyporesponsivity and enlarged cavum septi pellucidi in schizophrenia [Editorial]. Schizophrenia research. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 11 mar. 2026. , 2007 -
APA
Crippa, J. A. de S., Zuardi, A. W., Trzesniak, C., Hallak, J. E. C., Busatto Filho, G., & McGuire, P. K. (2007). No association between electrodermal hyporesponsivity and enlarged cavum septi pellucidi in schizophrenia [Editorial]. Schizophrenia research. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Crippa JA de S, Zuardi AW, Trzesniak C, Hallak JEC, Busatto Filho G, McGuire PK. No association between electrodermal hyporesponsivity and enlarged cavum septi pellucidi in schizophrenia [Editorial]. Schizophrenia research. 2007 ; 95 256-258.[citado 2026 mar. 11 ] -
Vancouver
Crippa JA de S, Zuardi AW, Trzesniak C, Hallak JEC, Busatto Filho G, McGuire PK. No association between electrodermal hyporesponsivity and enlarged cavum septi pellucidi in schizophrenia [Editorial]. Schizophrenia research. 2007 ; 95 256-258.[citado 2026 mar. 11 ] - Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
